Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheri A Dubey

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The Lancet. Microbe|May 11, 2022
Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trialsRebecca F Grais, Stephen B Kennedy, Barbara E Mahon, et al.
Nature Medicine|July 22, 2009
Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cellsNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.
Vaccine|October 8, 2022
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trialsJakub K Simon, Stephen B Kennedy, Barbara E Mahon, et al.
Plos One|January 5, 2011
Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionalityNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.
Mabs|October 23, 2015
Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell culturesKara S Cox, Aimin Tang, Zhifeng Chen, et al.
Cellular Immunology|April 13, 2010
Synthesis and immunological activities of novel agonists of toll-like receptor 9Mary Struthers, Andrew J Bett, Thomas Wisniewski, et al.
AIDS Research and Human Retroviruses|December 7, 2006
A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjectsTimothy W Tobery, Sheri A Dubey, Kiersten Anderson, et al.
Vaccine|October 14, 2015
Preclinical and clinical development of a dengue recombinant subunit vaccineSusan B Manoff, Sarah L George, Andrew J Bett, et al.
Nature Medicine|July 22, 2009
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humansKara L O'Brien, Jinyan Liu, Sharon L King, et al.
Vaccine|October 13, 2010
Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humansAndrew J Bett, Sheri A Dubey, Devan V Mehrotra, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The Lancet. Microbe|May 11, 2022
Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trialsRebecca F Grais, Stephen B Kennedy, Barbara E Mahon, et al.
Nature Medicine|July 22, 2009
Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cellsNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.
Vaccine|October 8, 2022
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trialsJakub K Simon, Stephen B Kennedy, Barbara E Mahon, et al.
Plos One|January 5, 2011
Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionalityNatalie A Hutnick, Diane G Carnathan, Sheri A Dubey, et al.
Mabs|October 23, 2015
Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell culturesKara S Cox, Aimin Tang, Zhifeng Chen, et al.
Cellular Immunology|April 13, 2010
Synthesis and immunological activities of novel agonists of toll-like receptor 9Mary Struthers, Andrew J Bett, Thomas Wisniewski, et al.
AIDS Research and Human Retroviruses|December 7, 2006
A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjectsTimothy W Tobery, Sheri A Dubey, Kiersten Anderson, et al.
Vaccine|October 14, 2015
Preclinical and clinical development of a dengue recombinant subunit vaccineSusan B Manoff, Sarah L George, Andrew J Bett, et al.
Nature Medicine|July 22, 2009
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humansKara L O'Brien, Jinyan Liu, Sharon L King, et al.
Vaccine|October 13, 2010
Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humansAndrew J Bett, Sheri A Dubey, Devan V Mehrotra, et al.
Pageof 3